Saletu 1995.
Methods | single centre, double blind, randomized, placebo controlled, parallel groups | |
Participants | MID mild to moderate; 24 patients received nicergoline, 26 placebo; age > 60 yr. | |
Interventions | Nicergoline or Placebo 30mg. twice a day (os) for 8 weeks | |
Outcomes | SCAG, MMSE, CGI, EEG/ERP for efficacy; side effects for safety | |
Notes |